Prostate radiation dose vs. incontinence & ED risk
Placeholder: imaging defines the prostate target and nearby critical organs.
Placeholder: CT/MRI fusion outlines prostate margins and organs at risk.
Placeholder: precise contouring is the foundation of a spared-tissue plan.
Placeholder: sphincter sits at the apex, nerve bundles run posterolateral.
Placeholder: closeness to target drives incidental dose and side-effect risk.
Placeholder: multiple beams converge on the prostate to build the prescribed dose.
Placeholder: beams cross at the target, summing dose only where they overlap.
Placeholder: overlap geometry concentrates dose inside the prostate.
Placeholder: higher doses improve tumor control but raise nearby-organ exposure.
Placeholder: splitting dose into fractions protects healthy tissue repair.
Placeholder: technique precision governs how much dose leaks beyond the target.
Placeholder: broader fields spill dose onto sphincter and nerve bundles.
Placeholder: wide fields trade precision for simplicity.
Placeholder: multi-leaf collimators sculpt dose tightly around the prostate.
Placeholder: daily imaging keeps tight margins accurate despite motion.
Placeholder: sphincter dose tracks incontinence risk, nerve dose tracks ED risk.
Placeholder: incidental sphincter dose raises long-term incontinence probability.
Placeholder: dose-volume thresholds guide acceptable sphincter exposure.
Placeholder: neurovascular bundle dose correlates with erectile dysfunction risk.
Placeholder: risk reflects total dose accumulated across all fractions.
Placeholder: modern precision techniques meaningfully lower incontinence and ED risk.
Placeholder: sculpted dose lowers but does not remove side-effect risk.
Placeholder: precision technique shifts the risk curve favorably.
Placeholder: adequate target dose is preserved while sparing nearby organs.
Placeholder: technique choice materially affects long-term quality of life.